Novel Inactivating Mutations of the Calcium-Sensing Receptor: The Calcimimetic NPS R-568 Improves Signal Transduction of Mutant Receptors
Authors:
Open Access
- 1 December 2008
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (12) , 4797-4803
Abstract
Context and Objective: Inactivating mutations in the calcium-sensing receptor (CaSR) gene cause neonatal severe hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH). The aims of the present study were the functional characterization of novel mutations of the CaSR found in FHH patients, the comparison of in vitro receptor function with clinical parameters, and the effect of the allosteric calcimimetic NPS R-568 on the signaling of mutant receptors. Methods: Wild-type and mutant CaSRs (W530G, C568Y, W718X, M734R, L849P, Q926R, and D1005N) were expressed in human embryonic kidney 293 cells. Receptor signaling was studied by measuring intracellular free calcium in response to different concentrations of extracellular calcium ([Ca2+]o). Results: Four CaSR mutations (C568Y, W718X, M734R, and L849P) demonstrated a complete lack of a [Ca2+]o-induced cytosolic Ca2+ response up to 30 mm [Ca2+]o, whereas the CaSR mutants W530G, Q926R, and D1005N retained some sensitivity to [Ca2+]o. There was no significant relation between the in vitro calcium sensitivity, serum calcium, and intact PTH levels in the patients. Patients with C-terminal CaSR mutations had a calcium to creatine ratio above the established diagnostic threshold of 0.01 for FHH. The calcimimetic NPS R-568 enhanced the responsiveness to [Ca2+]o in CaSR mutants of the extracellular domain (W530G and C568Y) as well as the intracellular C-terminal domain (Q926R and D1005N). Conclusion: Therefore, calcimimetics might offer medical treatment for symptomatic FHH patients, and more important, for patients with neonatal severe hyperparathyroidism that harbor calcimimetic-sensitive CaSR mutants.Keywords
This publication has 23 references indexed in Scilit:
- Alanine to Serine Polymorphism at Position 986 of the Calcium-Sensing Receptor Associated with Coronary Heart Disease, Myocardial Infarction, All-Cause, and Cardiovascular MortalityThe Journal of Clinical Endocrinology & Metabolism, 2007
- Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularlyHuman Molecular Genetics, 2006
- Clinical and laboratory features of calcium-sensing receptor disorders: a systematic reviewAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2004
- The Extracellular Calcium-sensing Receptor Dimerizes through Multiple Types of Intermolecular InteractionsJournal of Biological Chemistry, 2001
- Extracellular Calcium Sensing and Extracellular Calcium SignalingPhysiological Reviews, 2001
- Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal functionProceedings of the National Academy of Sciences, 1999
- Dimerization of the Extracellular Calcium-sensing Receptor (CaR) on the Cell Surface of CaR-transfected HEK293 CellsJournal of Biological Chemistry, 1998
- Disulfide Bonds in the Extracellular Calcium-Polyvalent Cation-sensing Receptor Correlate with Dimer Formation and Its Response to Divalent Cations in VitroJournal of Biological Chemistry, 1998
- Mapping of the calcium-sensing receptor gene (CASR) to human Chromosome 3q13.3-21 by fluorescence in situ hybridization, and localization to rat Chromosome 11 and mouse Chromosome 16Mammalian Genome, 1995
- Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroidNature, 1993